Emergence of SARS-CoV-2 Spike Escape Mutation Q493r After Bamlanivimab/Etesevimab Treatment for COVID-19

MLA

Daniele Focosi, et al. Emergence of SARS-CoV-2 Spike Escape Mutation Q493r After Bamlanivimab/Etesevimab Treatment for COVID-19. May 2021. EBSCOhost, https://doi.org/10.21203/rs.3.rs-524959/v1.

APA

Daniele Focosi, Angelo Genoni, Fabrizio Maggi, Daniela Dalla Gasperina, Francesco Dentali, Andreina Baj, & Federica Novazzi. (2021). Emergence of SARS-CoV-2 Spike Escape Mutation Q493r After Bamlanivimab/Etesevimab Treatment for COVID-19. https://doi.org/10.21203/rs.3.rs-524959/v1

Chicago

Daniele Focosi, Angelo Genoni, Fabrizio Maggi, Daniela Dalla Gasperina, Francesco Dentali, Andreina Baj, and Federica Novazzi. 2021. “Emergence of SARS-CoV-2 Spike Escape Mutation Q493r After Bamlanivimab/Etesevimab Treatment for COVID-19,” May. doi:10.21203/rs.3.rs-524959/v1.